Light-Induced Functional Pinealectomy: Expression of MT2 Receptors in Liver Cells of C57BL/6 Mice after Melatonin

S V Michurina1, S I Kolesnikov2,3, I Yu Ishchenko4

  • 1Research Institute of Clinical and Experimental Lymphology - Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. michurinasv3000@gmail.com.

Insights

Melatonin administration significantly increased MT2 receptor expression in mouse liver following light-induced pinealectomy. This finding highlights the role of MT2 receptors in melatonin synthesis disorders.

Area of Science:

  • Immunology
  • Endocrinology
  • Pharmacology

Background:

  • Disruptions in melatonin synthesis, often due to altered light exposure, can impact physiological processes.
  • The MT2 melatonin receptor plays a role in mediating melatonin's effects.
  • Understanding receptor expression is crucial for addressing melatonin-related disorders.

Purpose of the Study:

  • To investigate the effect of melatonin administration on MT2 melatonin receptor expression in the liver of mice with light-induced functional pinealectomy.
  • To assess the impact of constant light exposure on MT2 receptor levels.

Main Methods:

  • Immunohistochemical analysis using the avidin-biotin peroxidase ABC method.
  • C57BL/6 mice were subjected to 14 days of constant lighting to model functional pinealectomy.
  • Melatonin (1 mg/kg) or placebo was administered intragastrically for 14 days.

Main Results:

  • Light-induced functional pinealectomy and constant light exposure altered MT2 receptor expression.
  • Intragastric melatonin administration led to a 2-fold increase in the relative expression area of MT2 receptors in liver cells of pinealectomized mice.
  • Melatonin treatment did not significantly affect the intensity of MT2 receptor staining.

Conclusions:

  • MT2 melatonin receptors are significantly upregulated in the liver under conditions of disrupted melatonin synthesis.
  • Melatonin administration can modulate MT2 receptor expression, suggesting a therapeutic target.
  • These findings support the development of therapeutic strategies targeting melatonin receptors for melatonin synthesis disorders.